drugset / Trial / NCT06899841

Dexmedetomidine in Sonographic Guided Erector Spinae Plane Block

NCT06899841

Phase 2/3 Recruiting 90 enrolled Assiut University
RandomizedParallel-groupTriple-blindTreatment

Summary

to investigate the postoperative analgesic effect of dexmedetomidine addition with different doses as an adjuvant to bupivacaine to Erector spinae plane block after renal surgeries.

Timeline

Start
2024-10-01
Primary completion
2025-10-01
Completion
2026-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg
Subject Dexmedetomidine Other / unclassified 0.75 ug/kg
Subject Dexmedetomidine Other / unclassified 1 ug/kg

Indications

No indication recorded.